Wine: Does the colour count?

被引:42
作者
Goldberg, DM [1 ]
GarovicKocic, V [1 ]
Diamandis, EP [1 ]
PaceAsciak, CR [1 ]
机构
[1] HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA
关键词
wine; coronary heart disease; plasma lipids; lipoproteins; flavonoids; polyphenols; HDL-cholesterol;
D O I
10.1016/0009-8981(96)06229-8
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The objective of this study was to determine whether phenolic constituents present in red wine and grape juice modulate plasma lipid and lipoprotein concentrations in healthy human subjects. All subjects consumed in random order 375 ml of red or white wine per day or 500 ml of two different grape juices (high and low phenols) per day for periods of 4 weeks separated by 2-week periods of abstention while continuing normal activity and food intake, and their normal lives in a community setting. The subjects were 24 healthy males aged 26-45 years screened by clinical examination and laboratory tests to exclude hypertension, diabetes mellitus, hyperlipidemia and obesity, among others. Fasting blood was collected at the beginning and end of each beverage schedule for analysis of lipids and lipoproteins. Changes in plasma lipids and lipoproteins in response to each beverage were measured to determine whether these were altered by red wine and grape juice phenolics independently of the effects of ethanol. Both grape juices had virtually no effect. Red and white wines raised plasma HDL-cholesterol and apo A-I and apo A-II concentrations as well as the apo A-I:apo B ratio to a similar extent, Red wine also raised plasma triglyceride and total cholesterol concentrations. Neither wine affected plasma apo B or apo (a) concentrations. The favourable effects of wines in modulating plasma lipid and lipoprotein concentrations are probably due to their alcohol content and cannot be reproduced by grape juices.
引用
收藏
页码:183 / 193
页数:11
相关论文
共 41 条
[1]  
ARICHI H, 1982, CHEM PHARM BULL, V30, P1766
[2]   FAST ATOM BOMBARDMENT MASS-SPECTROMETRY OF BRADYKININ AND RELATED OLIGOPEPTIDES [J].
BARBER, M ;
BORDOLI, RS ;
SEDGWICK, RD ;
TYLER, AN ;
WHALLEY, ET .
BIOMEDICAL MASS SPECTROMETRY, 1981, 8 (08) :337-342
[3]   ALCOHOL AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL - A RANDOMIZED CONTROLLED TRIAL [J].
BURR, ML ;
FEHILY, AM ;
BUTLAND, BK ;
BOLTON, CH ;
EASTHAM, RD .
BRITISH JOURNAL OF NUTRITION, 1986, 56 (01) :81-86
[4]  
CAMARGO CA, 1985, JAMA-J AM MED ASSOC, V253, P2854
[5]   AN ANTIPLATELET PRINCIPLE OF VERATRUM-FORMOSANUM [J].
CHUNG, MI ;
TENG, CM ;
CHENG, KL ;
KO, FN ;
LIN, CN .
PLANTA MEDICA, 1992, 58 (03) :274-276
[6]   HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND APOPROTEIN-A1 IN HEALTHY-VOLUNTEERS DURING LONG-TERM MODERATE ALCOHOL INTAKE [J].
COUZIGOU, P ;
FLEURY, B ;
CROCKETT, R ;
RAUTOU, JJ ;
BLANCHARD, P ;
LEMOINE, F ;
RICHARDMOLARD, B ;
AMOURETTI, M ;
BERAUD, C .
ANNALS OF NUTRITION AND METABOLISM, 1984, 28 (06) :377-384
[7]   DOES DIET OR ALCOHOL EXPLAIN THE FRENCH PARADOX [J].
CRIQUI, MH ;
RINGEL, BL .
LANCET, 1994, 344 (8939-4) :1719-1723
[8]   MORTALITY IN RELATION TO CONSUMPTION OF ALCOHOL - 13 YEARS OBSERVATIONS ON MALE BRITISH DOCTORS [J].
DOLL, R ;
PETO, R ;
HALL, E ;
WHEATLEY, K ;
GRAY, R .
BRITISH MEDICAL JOURNAL, 1994, 309 (6959) :911-918
[9]   INHIBITION OF OXIDATION OF HUMAN LOW-DENSITY-LIPOPROTEIN BY PHENOLIC SUBSTANCES IN RED WINE [J].
FRANKEL, EN ;
KANNER, J ;
GERMAN, JB ;
PARKS, E ;
KINSELLA, JE .
LANCET, 1993, 341 (8843) :454-457
[10]   THE EFFECT OF ALCOHOL ON SERUM HIGH-DENSITY LIPOPROTEIN (HDL) - A CONTROLLED EXPERIMENT [J].
FRASER, GE ;
ANDERSON, JT ;
FOSTER, N ;
GOLDBERG, R ;
JACOBS, D ;
BLACKBURN, H .
ATHEROSCLEROSIS, 1983, 46 (03) :275-286